Page last updated: 2024-08-24

aripiprazole and tetradecanoylphorbol acetate

aripiprazole has been researched along with tetradecanoylphorbol acetate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, YH; Hashioka, S; Hirata, E; Horikawa, H; Inoguchi, T; Kanba, S; Kasai, M; Kato, TA; Maeda, Y; Mizoguchi, Y; Monji, A; Seki, Y; Sonoda, N; Utsumi, H; Yasukawa, K1

Other Studies

1 other study(ies) available for aripiprazole and tetradecanoylphorbol acetate

ArticleYear
Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia.
    Schizophrenia research, 2011, Volume: 129, Issue:2-3

    Topics: Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Brain; Calcium; Cells, Cultured; Drug Interactions; Electron Spin Resonance Spectroscopy; Microglia; NADPH Oxidases; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Superoxides; Tetradecanoylphorbol Acetate

2011